サマリー

欧州の透析器再処理装置市場は、2022年の224億3,820万米ドルから2030年には297億5,568万米ドルに達し、2023年から2033年の予測期間中に年平均成長率3.6％で成長すると予測されている。

市場細分化：
欧州透析器再処理装置市場：タイプ別（自動、半自動）、モダリティ別（ベンチトップ、スタンドアロン）、ステーションタイプ別（シングルステーション、デュアルステーション）、エンドユーザー別（病院、透析センター、ホームユース）、国別（ドイツ、イタリア、スペイン、ロシア、トルコ、ベルギー、その他欧州）-産業動向と2030年までの予測

欧州の透析器再処理装置市場ダイナミクスの概要

促進要因
- 末期腎不全（ESRD）の増加

抑制要因

- 厳しい承認規制

機会

- 技術の進歩

市場プレイヤー

欧州のダイアライザー再処理機市場で事業を展開する主な市場プレーヤーは以下の通りである：

- アトランティックバイオメディカル
- アドビンヘルスケア
- ゲリーファルコンヘルスケア社
- ザウバーン
- ウェスレー・バイオテック
- P.K.サイエンティフィック＆ケミカルズ
- クリニバヘルスケア
- メディベータ社（ステリス社子会社）
- その他

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW OF THE EUROPE DIALYZER REPROCESSING MACHINES MARKET 25
1.4 LIMITATIONS 26
1.5 MARKETS COVERED 27
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 CURRENCY AND PRICING 31
2.5 DBMR TRIPOD DATA VALIDATION MODEL 32
2.6 MULTIVARIATE MODELLING 35
2.7 TYPE LIFELINE CURVE 35
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.9 DBMR MARKET POSITION GRID 37
2.10 MARKET END USER COVERAGE GRID 38
2.11 VENDOR SHARE ANALYSIS 39
2.12 SECONDARY SOURCES 40
2.13 ASSUMPTIONS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 44
4.1 PESTEL ANALYSIS 45
4.2 PORTER’S FIVE FORCES MODEL 46
4.3 STRATEGIC INITIATIVES 47
5 EUROPE DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 48 
6 MARKET OVERVIEW 49
6.1 DRIVERS 51
6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 51
6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 51
6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 52
6.2 RESTRAINTS 53
6.2.1 STRINGENT REGULATIONS FOR APPROVAL 53
6.2.2 POSSIBLE RISK OF INFECTIONS 53
6.3 OPPORTUNITIES 54
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 54
6.3.2 INCREASING FOCUS ON INFECTION CONTROL 55
6.4 CHALLENGES 55
6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 55
6.4.2 LACK OF STANDARDIZATION 56
7 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 57
7.1 OVERVIEW 58
7.2 SEMI-AUTOMATIC 61
7.3 AUTOMATIC 62
8 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 63
8.1 OVERVIEW 64
8.2 BENCHTOP 67
8.2.1 SEMI-AUTOMATIC 68
8.2.2 AUTOMATIC 68
8.3 STANDALONE 68
8.3.1 SEMI-AUTOMATIC 69
8.3.2 AUTOMATIC 69
9 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 70
9.1 OVERVIEW 71
9.2 DUAL STATION 74
9.3 SINGLE STATION 75
10 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY END USER 76
10.1 OVERVIEW 77
10.2 DIALYSIS CENTERS 80
10.3 HOSPITAL 81
10.4 HOME USE 82
11 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY REGION 83
11.1 EUROPE 84
11.1.1 GERMANY 91
11.1.2 ITALY 93
11.1.3 SPAIN 95
11.1.4 RUSSIA 97
11.1.5 TURKEY 99
11.1.6 BELGIUM 101
11.1.7 REST OF EUROPE 103
12 EUROPE DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 104
12.1 COMPANY SHARE ANALYSIS: EUROPE 104
13 SWOT ANALYSIS 105
14 EUROPE DIALYZER REPROCESSING MACHINES MARKET 106
14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 106
14.1.1 COMPANY SNAPSHOT 106
14.1.2 REVENUE ANALYSIS 106
14.1.3 COMPANY SHARE ANALYSIS 107
14.1.4 PRODUCT PORTFOLIO 107
14.1.5 RECENT DEVELOPMENTS 107
14.2 HEMANT SURGICAL INDUSTRIES LTD. 108
14.2.1 COMPANY SNAPSHOT 108
14.2.2 REVENUE ANALYSIS 108
14.2.3 COMPANY SHARE ANALYSIS 109
14.2.4 PRODUCT PORTFOLIO 109
14.2.5 RECENT DEVELOPMENTS 109
14.3 SAUBERN 110
14.3.1 COMPANY SNAPSHOT 110
14.3.2 COMPANY SHARE ANALYSIS 110
14.3.3 PRODUCT PORTFOLIO 111
14.3.4 RECENT DEVELOPMENTS 111
14.4 P.K. SCIENTIFIC & CHEMICALS 112
14.4.1 COMPANY SNAPSHOT 112
14.4.2 PRODUCT PORTFOLIO 112
14.4.3 RECENT DEVELOPMENT 112 
14.5 LABSMED. 113
14.5.1 COMPANY SNAPSHOT 113
14.5.2 COMPANY SHARE ANALYSIS 113
14.5.3 PRODUCT PORTFOLIO 114
14.5.4 RECENT DEVELOPMENTS 114
14.6 ATLANTIC BIOMEDICAL 115
14.6.1 COMPANY SNAPSHOT 115
14.6.2 COMAPYN SHARE ANALYSIS 115
14.6.3 PRODUCT PORTFOLIO 116
14.6.4 RECENT DEVELOPMENT 116
14.7 ADVIN HEALTH CARE 117
14.7.1 COMPANY SNAPSHOT 117
14.7.2 PRODUCT PORTFOLIO 117
14.7.3 RECENT DEVELOPMENTS 117
14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 118
14.8.1 COMPANY SNAPSHOT 118
14.8.2 PRODUCT PORTFOLIO 118
14.8.3 RECENT DEVELOPMENT 118
14.9 CLINIVA HEALTHCARE 119
14.9.1 COMPANY SNAPSHOT 119
14.9.2 PRODUCT PORTFOLIO 119
14.9.3 RECENT DEVELOPMENT 119
14.10 GERYFALCON HEALTHCARE PVT. LTD. 120
14.10.1 COMPANY SNAPSHOT 120
14.10.2 PRODUCT PORTFOLIO 120
14.10.3 RECENT DEVELOPMENT 120
14.11 NANOTECH 121
14.11.1 COMPANY SNAPSHOT 121
14.11.2 PRODUCT PORTFOLIO 121
14.11.3 RECENT DEVELOPMENTS 121
14.12 WESLEY BIOTECH 122
14.12.1 COMPANY SNAPSHOT 122
14.12.2 PRODUCT PORTFOLIO 122
14.12.3 RECENT DEVELOPMENT 122
15 QUESTIONNAIRE 123
16 RELATED REPORTS 126